Rahul G Argula (@RahulArgula) header
Rahul G Argula (@RahulArgula) profile picture

Husband, Dad, Crossword nerd, Classic Rock devotee, Politics junkie, Pulmonary/Critical care doc, Physiology buff, passionate about Pulmonary vascular disease.

Charleston, SC
Joined November 2017
Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)Photo by Rahul G Argula (@RahulArgula)
Rahul G Argula retweeted
As we enter the sotatercept era and move beyond vasodilators alone for PAH, we find that roughly 10% get high output states from vasodilators that is missed on non-invasive testing and worsens RV work due to volume load despite marked PVR reduction. publications.ersnet.org/cont…
2
8
30
1,953
Had a great conversation about BMPR signal modulation from the guru himself @bmprii . Arguably, the most consequential and paradigm changing work that helps the right ventricles of PAH patients. Wait, where is @RyanTedfordMD ?
1
15
1,257
Amazing two days at PHA 2024. Felt the energy after connecting with the PH community. I’m so glad that the entire MUSC PVD team (except Denise :( )got to experience PHA this year. MUSC was well represented. Grateful for all the talented and hardworking people that I work with.
7
296
This is one of the best commencement addresses I've seen.
“The kindest person in the room is often the smartest.”
2
498
Great study! iNO consumes a significant amount of resources in health systems. Substitution of iNO with iEPO can translate into significant cost savings!
1
1
6
1,061
Great thread! Nice work @DrTimFernandes , @nickhsk_phdoc
I'm pleased to share this new, important paper from our group @ucsdhealth on distal pulmonary thromboendarterectomy results in #CTEPH. Outcomes were similar for distal (Level 3/4) vs. proximal disease (Level 1/2). 🔑 points in 🧵: sciencedirect.com/science/ar…
6
524
If you are planning on attending ATS 2023 and have an interest in PH in the SSc patient, don't forget to register for my talk. See below for details. The registrations are limited, on a first come first serve basis (not my rules sorry) so don't wait for the last minute.
Interested in learning about pulmonary hypertension (PH) in Systemic sclerosis (SSc) ? Join me for a talk at #ATS2023 about the complex and overlapping phenotypes of PH in SSc & their Rx using case studies from our multi-disciplinary SSc program at MUSC. abstractsonline.com/pp8/#!/1…
1
13
1,446
Interested in learning about pulmonary hypertension (PH) in Systemic sclerosis (SSc) ? Join me for a talk at #ATS2023 about the complex and overlapping phenotypes of PH in SSc & their Rx using case studies from our multi-disciplinary SSc program at MUSC. abstractsonline.com/pp8/#!/1…
1
7
1
26
3,579
You will have to register to be able to attend the talk. Session details: MTE49- PHENOTYPING SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY HYPERTENSION
1
232
Strong work by @SamFriedman90 and @sese_denise #risingsuperstars. Couldn’t be more proud of them. I heard @doc_vlach may join the club soon! @MUSChealth @MUSC_COM @MedUnivSC @MUSC_IM
Great work by our PH fellow @SamFriedman90 presenting data from the PHAROS registry and our case of liver avms as a CTEPH mimic at #CHEST2022 @RahulArgula @RyanTedfordMD
1
14
Of course there was a @RyanTedfordMD talk! Preload insufficiency - something to think about in our unexplained dyspnea patients. Not a lot of evidence but a great summary and presented in the inimitable RJT style! @MUSChealth #CharlestonHFpEFconference.
2
7
59
PH and Cardiology Tweeps, doing a talk on RV failure in the ICU in a few months. Would love any pointers w.r.t, review articles, position papers, pearls, etc. @rjbernardoMD @DrRisbo @belindariveramd @heresi_gustavo @SandeepSahayMD @RyanTedfordMD @Brian_Houston12
2
7
Enjoyed the sessions and the energy at #PHA2022. Proud of our awesome team that put together this poster describing our experience with home IV to PO prostacyclin transitions in carefully chosen PAH patients. @sese_denise #MeghanMorrisette, #KristineRitenour, #MUSC
1
2
13
And it’s a wrap. Poster #2 for @SamFriedman90 . #MeganVeglia was an equal contributor to this. Just accepted to the Annals of ATS. Will post link when available. Capped off the evening with my pulm peeps!#ATS2022 has been an amazing experience so far.
1
6
Rock star alert!
What happens when the cells that help you heal cause harm instead? In this episode of Science Never Sleeps, we sit down with Dr. Carol Feghali-Bostwick to discuss scleroderma, fibrosis and the research being done to find treatments and possible cures. https://nitter.cf/t.co/NvYP2gzHUy
1
3
#ATS2022 has been busy for the MUSC PVD program. Proud of #ElenaVlachos for her presentation today. @MUSChealth @KidneyPrince @SamFriedman90
2
3
16
Great job by @SamFriedman90 on the poster discussion. #ATS2022 is off to a great start. @MUSChealth has had a strong showing today!
11
Very helpful @rjbernardoMD thank you for doing this!
#ATS2022 is here! For my #PHPEEPS and #PHaficionados, some of the lectures you don’t wanna miss are… 🧵 @ATS_PC
2